Skip to content

Thyroid Dysfunction and Obstetric Complications

Thyroid Dysfunction and Obstetric Complications

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02815501
Acronym
TDOC
Enrollment
0
Registered
2016-06-28
Start date
2012-03-01
Completion date
2017-10-26
Last updated
2020-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Thyroid dysfunction, obstetric complications

Brief summary

Obstetric complications are common and can be responsible for maternal and foetal morbidity and mortality. Thyroid dysfunction has been identified as a possible cause of obstetric complications. Many studies have been conducted to estimate the prevalence and define the nature of obstetric complications observed in patients with thyroid dysfunction. However, women with obstetric complications are not systematically screened for thyroid dysfunction and no published study has evaluated the prevalence of thyroid dysfunction in women with an obstetric complication. As no consensus has been reached concerning systematic screening for thyroid dysfunction in pregnant women, the identification of new high-risk populations could possibly result in a change of clinical practice.

Interventions

BIOLOGICALblood samples

for the determination of thyroid hormones (TSH, FT3, FT4 ) and antibodies against the thyroid (anti TPO antibodies and anti thyroglobulin)

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

women attending the emergency room and/or hospitalised or followed for: * Spontaneous and/or repeated miscarriage * Foetal death * Pre-eclampsia * Retroplacental haematoma * Post-partum haemorrhage * Premature delivery * who consent to participate in the study. * Assessment of these women will include blood samples for a laboratory work-up and anti-thyroid antibodies.

Exclusion criteria

* normal pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of thyroid dysfunctionDay 0Estimate the overall and individual prevalence of thyroid dysfunction (hypothyroidism, hyperthyroidism and thyroid autoimmunity) in patients with obstetrical accident

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026